Key result
Mitral valve surgery at a South African academic hospital had an overall peri-operative mortality rate of 6.1%, with rheumatic heart disease being the primary etiology.
Why the study?
Data on mitral valve surgery outcomes in South Africa are limited, where rheumatic heart disease remains a major public health challenge.
Observational (n=213)
No
In a South African cohort where rheumatic heart disease is the primary etiology, mitral valve surgery had a 6.1% peri-operative mortality rate, which was strongly predicted by advanced NYHA class, low LVEF, and other pre-operative comorbidities.
Observational data from this setting should not change practice; leaves open need for multicenter studies on RHD surgical outcomes.
Background: The distribution and determinants of heart disease vary greatly between high-income countries and sub-Saharan Africa where rheumatic heart disease (RHD) is a major public health challenge. Studies from Africa report that RHD is the main cause of cardiovascular morbidity and mortality in the young. Data on mitral valve surgery outcomes in South Africa are limited. The aim of this study was to describe the peri-operative outcomes of patients that have undergone mitral valve surgery at the Charlotte Maxeke Johannesburg Academic Hospital (CMJAH). Methods: All patients older than 18 years who underwent mitral valve surgery at CMJAH between 1 January 2015 and 31 December 2018 were retrospectively included. Cardiac intensive care records including anaesthesia charts were assessed to describe preoperative, intra-operative and post-operative data of each patient. Pre-operative data included patient demographics and comorbidities. Intra-operative data included aortic clamp and bypass times. Post-operative variables included outcomes such as sepsis, bleeding, re-operation, and the development of acute kidney injury (AKI). The pre-operative, intra-operative and post-operative outcomes were compared to determine the effect each variable had on post-operative mortality. Results: Two hundred and seventeen patients underwent mitral valve surgery at CMJAH between 1 January 2015 and 31 December 2018. Four patients’ records were incomplete. RHD was found to be the primary aetiology for mitral valve surgery at CMJAH with a mortality rate of 6.1%. Pre-operative findings that contributed to mortality were: EuroSCORE>2%, preoperative ventilation, dialysis dependence, pre-operative inotropic support, chronic obstructive pulmonary disease, congestive cardiac failure, renal insufficiency, low ejection fraction and New York Heart Association functional class ≥III. Post-operative findings that contributed to increased mortality were prolonged mechanical ventilation, pneumonia, re-operation, AKI, sepsis, bleeding, and transfusion. Increased aortic clamping and cardiopulmonary bypass times increased the risk of prolonged mechanical ventilation, re-operations, pacemaker implantations, AKI, and bleeding. Conclusions: RHD was found to be the primary aetiology for mitral valve surgery at CMJAH with a mortality of 6.1%. Pre-operative, intra-operative and post-operative predictors of outcomes in this study confirm observations made in other parts of the world.
No takes yet. Share an insight, caveat, or question.
Tabane et al. (2021) conducted an observational in Mitral valve disease (n=213). Mitral valve surgery was evaluated on Peri-operative mortality. Mitral valve surgery at a South African academic hospital had an overall peri-operative mortality rate of 6.1%, with rheumatic heart disease being the primary etiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: